menu
    • menu

    Company profile for Shield Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals that address patients’ unmet medical needs, with an initial focus on addressing anaemia associated with renal and gastrointestinal disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shield Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    120 New Cavendish Street London W1W 6XX
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.shieldtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shield Provides Full Year Trading Update and Reports Progress
    Shield Provides Full Year Trading Update and Reports Progress

    18 Feb 2022

    // PRESS RELEASE

    https://www.shieldtherapeutics.com/shield-provides-full-year-trading-update-and-reports-progress-on-the-commercialization-of-accrufer-feraccru/

    PRESS RELEASE
    18 Feb 2022
    Share Share
    Shield Therapeutics to Webcast Live at Life Sciences Investor Forum June 24th
    Shield Therapeutics to Webcast Live at Life Sciences Investor Forum June 24th

    21 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/21/2250261/0/en/Shield-Therapeutics-PLC-Shield-to-Webcast-Live-at-Life-Sciences-Investor-Forum-June-24th.html

    GLOBENEWSWIRE
    21 Jun 2021
    Share Share
    "China licence agreement for Feraccru/Accrufer

    08 Jan 2020

    // SHARES

    https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer

    SHARES
    08 Jan 2020
    Share Share
    "China licence agreement for Feraccru/Accrufer

    07 Jan 2020

    // SHARES

    https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer

    SHARES
    07 Jan 2020
    Share Share
    "China licence agreement for Feraccru/Accrufer

    07 Jan 2020

    // SHARES

    https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer

    SHARES
    07 Jan 2020
    Share Share
    What Investors Should Know About Shield Therapeutics' Financial Strength
    What Investors Should Know About Shield Therapeutics' Financial Strength

    31 Oct 2018

    // Terrence Jolly SIMPLY WALL STREET

    https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-stx/shield-therapeutics-shares/news/what-investors-should-know-about-shield-therapeutics-plcs-lonstx-financial-strength/

    Terrence Jolly SIMPLY WALL STREET
    31 Oct 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search